1. MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development
- Author
-
Liu, X, Chan, KM, Liu, B, Cheah, KSE, Zhou, Z, Jin, G, Zhang, F, Xavier Wong, HL, Liu, D, and Mauch, C
- Subjects
stomatognathic system ,B-cell differentiation ,Dll1 ,MT1-MMP ,embryonic structures ,Notch signalling ,Receptors, Notch - metabolism ,Cell Differentiation ,Intercellular Signaling Peptides and Proteins - metabolism ,Matrix Metalloproteinase 14 - deficiency - metabolism ,B-Lymphocytes - physiology - Abstract
Notch signalling controls the differentiation of haematopoietic progenitor cells (HPCs). Here, we show that loss of membrane-type 1 matrix metalloproteinase (MT1-MMP, MMP14), a cell surface protease expressed in bone marrow stromal cells (BMSCs), increases Notch signalling in HPCs and specifically impairs B-lymphocyte development. When co-cultured with BMSCs in vitro, HPCs differentiation towards B lymphocytes is significantly compromised on MT1-MMP-deficient BMSCs and this defect could be completely rescued by DAPT, a specific Notch signalling inhibitor. The defective B-lymphocyte development could also be largely rescued by DAPT in vivo. MT1-MMP interacts with Notch ligand Delta-like 1 (Dll1) and promotes its cleavage on cell surface in BMSCs. Ectopic MT1-MMP cleaves Dll1 and results in diminished Notch signalling in co-cultured cells. In addition, recombinant MT1-MMP cleaves a synthetic Dll1 peptide at the same site where MT1-MMP cleaves Dll1 on the cell surface. Our data suggest that MT1-MMP directly cleaves Dll1 on BMSCs to negatively regulate Notch signalling to specifically maintain normal B-cell development in bone marrow. © 2011 European Molecular Biology Organization., postprint
- Published
- 2011